Medical

MAP3K11

MAP3K11

An oncogene on chromosome 11q13.1-q13.3 that encodes a MAPK kinase kinase belonging to a protein kinase signal transduction cascade. MAP3K11 activates the JUN N-terminal pathway; it is required for serum-stimulated cell proliferation and for mitogen and
cytokine activation of MAPK14/p38, MAPK3/ERK and MAPK8/JNK1, through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. MAP3K11 plays a role in mitogen-stimulated phosphorylation and activation of BRAF; it influences microtubule organisation during the cell cycle, and is expressed in a wide range of benign and malignant tissues.

Each mitogen-activated protein kinase (MAPK) pathway is a conserved cascade of three protein kinases: an activated MAPK kinase kinase (MAPKKK) phosphorylates and activates a specific MAPK kinase (MAPKK), which in turn activates a specific MAPK.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
References in periodicals archive
Eight hours after RD cells were infected with EV71, the expression levels of c-Jun, c-Fos, IFN-[beta], MEKK1 (MAP3K1), MLK3 (MAP3K11) and NIK (MAP3K14) revealed 2.08-6.12 fold enhancement, while other 19 genes (e.g.
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.